COVID-19: One week of vaccines: What are we doing well? What can be done better?
It has been a week since South Africa started its mass rollout for 60-year-olds and older. Nathan Geffen and Marcus Low assess the rollout so far.
It has been a week since South Africa started its mass rollout for 60-year-olds and older. Nathan Geffen and Marcus Low assess the rollout so far.
Messenger RNA (mRNA) vaccines, such as the COVID-19 vaccines made by Moderna and Pfizer/BioNTech, have been hailed for their manufacturing advantages over conventional vaccines – so much so that African leaders such as President Cyril Ramaphosa has called for mRNA production capacity to be developed in Africa. Catherine Tomlinson examines why mRNA vaccines are easier to make than some other types of vaccines and asks what it will take to build such production capacity.
Four years ago, the virtual collapse of cancer services in KwaZulu-Natal saw some desperate patients move to Gauteng for care. Now, a new crisis is again prompting those who can, to relocate for treatment. Laura Lopez Gonzalez reports.
The COVID-19 pandemic caused huge setbacks for the fight against TB. Now, provinces are developing TB catch-up plans. The Western Cape Department of Health will soon launch a TB dashboard as part of its “multi-sectorial TB emergency response plan”. Tiyese Jeranji reports.
Service delivery protests in Mangaung in the Free State have disrupted the vaccine rollout in the metro. Vaccinations are on hold for now, reports Refilwe Mochoari.
It is little wonder that some TB vaccine researchers suffer from a rare syndrome that understandably threatens their mental health. Symptoms include frustration, impatience, irritability, seemingly inexplicable rage, and in the least resilient, despair. It’s called VJS or vaccine jealousy syndrome, writes Chris Bateman.
Phase II of South Africa’s vaccination rollout has started. Elri Voigt unpacks how provinces will go about vaccinating those aged 60 and older.
When South Africa’s rollout of the AstraZeneca vaccine was put on hold in early February, a scramble ensued to ensure healthcare workers could be protected. Chris Bateman spoke to Professor Glenda Gray about the behind-the-scenes negotiations that helped secure 500 000 doses of the Johnson & Johnson vaccine – almost all of which have now been used in the Sisonke study.
Starting now, hundreds of thousands of COVID-19 vaccines will be arriving in South Africa weekly. Rather than spending energy and resources policing who gets them, we should be focusing on getting the vaccines as fast as possible into willing arms. Don’t try to micro-manage the rollout, writes Nathan Geffen and Marcus Low.
South Africa will delay introducing a new HIV and TB plan until 2024, Deputy President David Mabuza revealed on Wednesday. The plan is delayed to allow the country’s HIV and TB responses to recover from COVID-19-related disruptions. Laura Lopez Gonzalez reports for Spotlight.
As Charlotte Maxeke Hospital missed its date to reopen this month after a fire in April, there are concerns that the true cost of the fire is still to be counted and that the fire is just another indication of a health department and fire service in crisis. Ufrieda Ho reports
With the COVID-19 mass vaccination rollout set to start on 17 May, many more people, for now, those older than 60 years, will receive their jabs. Elri Voigt looked into what, if anything, will change for those who have been vaccinated, and what other countries have done in this regard.